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Edited by Hans EklundAbstract Two open reading frames (ORFs), alr0295 and
alr2325, are found to encode putative cAMP receptor proteins
(CRPs) in the genome of the ﬁlamentous cyanobacterium
Anabaena sp. PCC 7120. These ORFs were named cAMP
receptor protein-like gene A in Anabaena sp. PCC 7120
(ancrpA) and cAMP receptor protein-like gene B in Anabaena
sp. PCC 7120 (ancrpB), respectively, and those translated
products were investigated. The equilibrium dialysis measure-
ments revealed that AnCrpA bound with cAMP speciﬁcally,
while AnCrpB bound with both cAMP and cGMP, though the
aﬃnity for cGMP was weak. The binding aﬃnity for cAMP of
AnCrpA showed the lowest dissociation constant, approximately
0.8 lM, among bacterial CRPs. A gel mobility shift assay
elucidated that AnCrpA and AnCrpB formed a complex with the
consensus DNA sequence in the presence of cAMP, although
AnCrpB did not have ordinary DNA-binding motifs.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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cAMP is an important signaling molecule in prokaryotes
and eukaryotes. It is synthesized from ATP by adenylate
cyclases in response to extracellular stimuli. In enteric bacteria,
cAMP regulates the expression of the alternative catabolic
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Escherichia coli CRP is known to regulating the activity of
over 100 genes. The crystal structure of CRP has been deter-
mined, and the mode of binding to cAMP, consensus DNA
sequence and a subunit COOH-terminal domain of RNA
polymerase has been revealed [2–6].
Cyanobacteria are Gram-negative and are able to carry out
higher plant-type oxygen-evolving photosynthesis. It has been
shown that cellular cAMP levels change in response to envi-
ronmental stimuli such as light–dark, low pH–high pH, oxic–
anoxic [7,8], and nitrogen replete–deplete [9]. The ﬁlamentous
cyanobacterium, Anabaena sp. PCC 7120, has the simulta-
neous abilities of oxygen-evolving photosynthesis and nitrogen
ﬁxation. This cyanobacterium has six genes coding adenylate
cyclases [10,11], one of which, cyaB1, is self-activated by
cAMP [12]. However, the physiological function of cAMP in
Anabaena sp. PCC 7120 remains unknown. In a unicellular
cyanobacterium Synechocystis sp. PCC 6803, an adenylate
cyclase gene cya1 was identiﬁed and the cya1 disruption mu-
tant displayed immotility [13]. In addition, the gene for cAMP
receptor protein, sycrp1, was identiﬁed from a Synechocystis
sp. PCC 6803 [14]. The cAMP receptor protein in Synecho-
cystis sp. PCC 6803 (SYCRP1) acts as a transcriptional acti-
vator in vivo [15] and the phenotype of the gene disruption of
sycrp1 displayed reduction in the number of thick pili and
immotility [16]. These results indicated that cAMP and
SYCRP1 are involved in the regulatory mechanism of cell
motility.
The analysis of entire DNA sequence of the Anabaena sp.
PCC 7120 genome has been completed [17,18]. Putative CRP
coding genes were searched in the whole genome and seven
open reading frame (ORF) products of the CRP family have
been predicted [18]. Among the seven ORFs, ntcA (alr4392)
[19–22] and devH (alr3952) [23] annotated to be related to
nitrogen metabolism, and the others two ORFs (alr0295 and
alr2325) showed a high similarity to sycrp1. Consequently,
Alr0295 and Alr2325 are named AnCrpA and AnCrpB, re-
spectively. In this study, we investigated biochemical charac-
teristics of these two CRPs of Anabaena sp. PCC 7120.2. Materials and methods
2.1. Bacterial strains, plasmids and growth media
The E. coli strains used as hosts were JM109 [recA1, endA1, gyrA96,
thi, hsdR17(rK, mKþ)], supE44, relA1, and D(lac-proAB)/F0 [traD36,ation of European Biochemical Societies.
T. Suzuki et al. / FEBS Letters 571 (2004) 154–160 155proAB, lacIq, D(lacZ)M15] for cloning and BL21(DE3) [F, ompT,
hsdS (rB, mB), dcm, gal, k(DE3)] for the expression of recombinant
proteins. Bacteria were grown in Luria–Bertani medium [24]. When
required, kanamycin, chloramphenicol, or ampicillin was added at 25,
30, or 100 lgml1, respectively.
2.2. Construction of expression plasmids for recombinant proteins
To obtain DNA fragments corresponding to alr0295 and alr2325
ORFs (cAMP receptor protein-like gene A in Anabaena sp. PCC 7120
(ancrpA) and cAMP receptor protein-like gene B in Anabaena sp. PCC
7120 (ancrpB), respectively), polymerase chain reactions (PCRs) were
performed with several sets of synthetic primers and genomic
DNA from Anabaena sp. PCC 7120. The primers for ancrpA were
RPA1 (50-CGGGATCCATGGAAGACCGATATA-30) and RPA2
(50-CATCTGGCAGAGAATCT-30). Primers for ancrpB were RPB1
(50-CGGGATCCATGCAAACTGAGGTTT-30) and RPB2 (50-CC-
TCAAATATCAGGTGT-30). The sequences of the RPA1 and RPB1
primers were designed to allow the introduction of a BamHI restriction
site immediately upstream of the initiator ATG codon. Each PCR
product was cloned into pGEM-T Easy vector (Promega, Madison).
After veriﬁcation of the nucleotide sequence, ancrpA and ancrpB were
digested from each plasmid with BamHI and EcoRI and cloned be-
tween the BamHI and EcoRI sites of the pET-28a expression vector
(Novagen). The resulting plasmids were named pRPA and pRPB,
respectively.
2.3. Expression and puriﬁcation of recombinant proteins
The transformants, BL21(DE3) cells harboring each of the pRPA
and pRPB plasmids, were grown at 37 C in 1.5 liter Luria–Bertani
medium supplemented with kanamycin (25 lgml1). The recombinant
genes were expressed in an optical density at 600 nm of 0.4 by adding 1
mM isopropyl-b-D-thiogalactopyranoside (IPTG), and incubation was
continued for 3 h at 37 C for BL21(DE3) harboring pRPA and
overnight at 20 C for BL21(DE3) harboring pRPB.
Following Yoshimura et al. [14], E.coli cells were broken using a
sonicator (model 200 M, Kubota Co., Tokyo, Japan), and His-tagged
proteins were puriﬁed through a HiTrap Chelating column (Amersham
Pharmacia Biotech; 1.6 2.5 cm) and a HiTrap Q column (Amersham
Pharmacia Biotech; 1.6 2.5 cm) connected to a fast protein liquid
chromatography system (FPLC system, Amersham Pharmacia Bio-
tech) by the same methods of His-SYCRP1. His-tagged AnCrpA (His-
AnCrpA) or His-tagged AnCrpB (His-AnCrpB) was eluted from the
HiTrap Q column with 50 mM Tris–HCl (pH 8.0), 200 mM NaCl and
10% (w/v) glycerol, respectively.Fig. 1. Modular architecture scheme and amino-acid sequence alignment. (A
cNMP and HTH indicate cyclic nucleotide-monophosphate binding domain a
coli CRP, Anabaena sp. PCC 7120 AnCrpA and AnCrpB. The asterisks mark
E. coli CRP structure [4]. The closed circle represents residues that form hyd
sequences are shown by black boxes. Numbers at the left of the sequence in2.4. Equilibrium dialysis and assay for bound nucleotides by
reversed-phase HPLC
The procedure of equilibrium dialysis and the measurement of the
amounts of nucleotides using a high-performance liquid chromatog-
raphy (HPLC) system (Shimadzu Co., Kyoto, Japan) have been de-
scribed previously [14]. To equilibria, samples were incubated for 6 h
at 20 or 30 C in 50 mM Tris–HCl (pH 8.0), 200 mM NaCl and 10%
(w/v) glycerol. Dialysis membrane was purchased from Viskase
Companies, Inc. (pore size 50 A). The concentrations of the re-
combinant proteins and nucleotides are indicated in the legends of
Figs. 3 and 4.
A TSK ODS-80Ts column (4.6 mm 15 cm, TOSOH Co., Tokyo,
Japan) was used in HPLC analysis. Samples were assayed with 30 mM
sodium phosphate buﬀer (pH 6.5) containing 5% (v/v) acetonitrile and
the eﬄuent was monitored at 259 nm. The ﬂow rate was 1.0 mlmin1
and the injection volume was 10 ll.
2.5. Gel mobility shift assay
Gel mobility shift assay was carried out as described previously [14].
A sequence of the oligonucleotide includes a consensus DNA sequence
for E. coli CRP binding and a BamHI sequence attached to the 50-end
of the consensus sequence (50-CGGGA TCCGCGAAAAGTGTGA-
CATATGTCACACTTTTCGC-30) was synthesized. Preparation of
double strand DNA was attained by incubating the oligonucloetide at
95 C for 1 min, 60 C for 10 min and 25 C for 1 h in 50 mM Tris–HCl
(pH 7.5) containing 100 mM NaCl and 1 mM dithiothreitol. The 32P-
labeled DNA (10,000 cpm, approximately 1 ng) was incubated with
His-AnCrpA or His-AnCrpB in a total volume of 20 ll of the binding
buﬀer (50 mM Tris–HCl (pH 8.0), 60 mMNaCl, 1 mM EDTA, 8% (w/
v) glycerol, and various volumes of poly(dI–dC)) with or without a
ﬁnal concentration of 20 lM cAMP for His-AnCrpA, and 200 lM
cAMP for His-AnCrpB for 30 min at room temperature. After the
incubation, samples were loaded onto 5% polyacrylamide gels (acryl-
amide:N,N0-methylenebisacrylamide, 50:1). The electrophoresis buﬀer
was 0.25TBE with or without 20 lM cAMP for His-AnCrpA and
200 lM cAMP for His-AnCrpB. The resulting gels were dried and
visualized in a Fujix BAS1000 system (Fuji Film).
2.6. Other analytical procedures
The protein concentration was determined using Protein Assay Dye
Reagent (Bio-Rad) and bovine serum albumin was used as the stan-
dard. SDS–polyacrylamide gel electrophoresis (PAGE) was carried out
in polyacrylamide gels containing 0.1% SDS by the method of Lae-
mmli [25].) The domain abbreviations of AnCrpA and AnCrpB are indicated.
nd helix–turn–helix domain, respectively. (B) Sequence alignment of E.
amino acid residues that function in binding the cAMP molecule to the
rogen bonds with DNA [4]. Residues identical if more than two of the
dicate the corresponding residue positions.
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The cAMP-binding motif in the prokaryotic cAMP recep-
tor protein and in the eukaryotic regulatory subunit of
cAMP-dependent protein kinase is well conserved [26–28].
Using the list of the CRP family in Anabaena sp. PCC 7120
[18], we narrowed down the candidates for CRP based on its
conserved amino acid residues that interact with the cAMP
molecule in E. coli CRP. Consequently, two ORFs, alr0295
and alr2325, satisﬁed the requirements and were named
ancrpA and ancrpB, respectively. Predicted AnCrpA consists
of a cNMP-binding domain and a helix–turn–helix domain
(Fig. 1A) similar to other bacterial CRPs. Another predicted
AnCrpB has a cNMP-binding domain, but lacks the ordinary
DNA-binding domain (Fig. 1A). A sequence alignment of E.
coli CRP, AnCrpA and AnCrpB (Fig. 1B) shows that the
respective AnCrpA and AnCrpB share with E. coli CRP in
ﬁve of the seven residues that are involved in binding with the
cAMP molecule. Unpreserved residues for AnCrpA and
AnCrpB, Thr-127 and Ser-128, have been proved to interact
with the adenine ring, and did not appreciably aﬀect the
cAMP-binding aﬃnity of E. coli CRP [29–32]. Moreover,
SYCRP1, which does not conserve these amino acid residues,
possessed the cAMP-binding aﬃnity [14]. Thus, though
AnCrpA and AnCrpB do not have these residues, they could
exhibit cAMP binding. E. coli CRP contains a helix–turn–
helix domain as a DNA-binding domain in the carboxyl-
terminal region [4,33]. AnCrpA shows high homology to the
latter helix in that of E. coli CRP, a so-called ‘‘recognition
helix.’’ Also, Arg-180, Glu-181 and Arg-185 of E. coli CRP
are known to interact directly with the DNA major groove
[4], and are conserved in AnCrpA (Fig. 1B). Anabaena sp.
PCC 7120 genome data were derived from the CyanoBase
[34] and the prediction of a secondary structure was estab-Fig. 2. Overexpression and puriﬁcation of His-AnCrpA and His-
AnCrpB. SDS–PAGE was preformed using a 12% polyacrylamide gel,
stained with Coomassie Brilliant Blue R-250. Lane 1, cell extract of
BL21(DE3) harboring pRPA after the addition of 1 mM IPTG (15 lg);
Lane 2, His-AnCrpA (4 lg); Lane 3, cell extract of BL21(DE3) har-
boring pRPB after the addition of 1 mM IPTG (15 lg); Lane 4, His-
AnCrpB (4 lg). M represents molecular mass markers.lished by referring to SMART [35]. Protein identities were
calculated from a CLUSTAL W [36].
Fig. 2 shows the each puriﬁed recombinant protein, His-
AnCrpA and His-AnCrpB, respectively. The respective molec-
ularmass of bothHis-AnCrpAandHis-AnCrpBwere estimated
to be 29 and 28 kDa by the SDS–PAGE analysis. These values
agreed well with the theoretical values.
To determine the cAMP-binding ability of each expressed
protein, equilibrium dialysis measurements were performed
using these recombinant proteins and nucleotides at 20 C.
Fig. 3A shows that approximately 3.5 lM cAMP was bound
with 10 lM His-AnCrpA, whereas neither cGMP nor 50-AMP
were thus bound. To investigate the binding speciﬁcity of His-
AnCrpA to cAMP, equilibrium dialysis measurements were
performed using 10 lM His-AnCrpA and high concentrations
of 25 lM and 50 lM cGMP and 50-AMP, respectively. His-
AnCrpA did not bind with either cGMP or 50-AMP even at
high concentrations (data not shown). As for His-AnCrpB,
approximately 0.75 lM cAMP and 0.2 lM cGMP bound withFig. 3. Binding activity of nucleotides to recombinant proteins mea-
sured by equilibrium dialysis. (A) 10 lM His-AnCrpA was incubated
for 6 h in the presence of 10 lM cAMP, 10 lM cGMP, or 10 lM 50-
AMP at 20 C. (B) 25 lM His-AnCrpB was incubated for 6 h in the
presence of 10 lM cAMP, 10 lM cGMP, or 10 lM 50-AMP at 20 C.
The amount of each bound nucleotide was measured by HPLC.
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(Fig. 3B). These data indicate that His-AnCrpA has a speciﬁc
and strong aﬃnity to cAMP, while His-AnCrpB has lower
speciﬁcity and weaker aﬃnity to the cyclic nucleotide than
His-AnCrpA.
To obtain the Kd values of His-AnCrpA and His-AnCrpB
for cAMP, various concentrations of cAMP were incubated
with 2 lMHis-AnCrpA or 25 lMHis-AnCrpB for 6 h at 20 or
30 C for equilibrium dialysis. The Kd value was determined
from the slope of the regression line by least-square analysis on
a Scatchard plot (Fig. 4A and B). The obtained Kd value of
His-AnCrpA for cAMP was 0.78 lM at 20 C and 0.84 lM atFig. 4. Scatchard plot from cAMP bound to recombinant proteins by
equilibrium dialysis. (A) 2 lM His-AnCrpA was incubated for 6 h in
the presence of 0.5–25 lM of cAMP at 20 C (m) or 30 C (d). (B) 25
lMHis-AnCrpB was incubated for 6 h in the presence of 0.5–50 lM of
cAMP at 20 C (m) or 30 C (d). The amounts of bound cAMP were
measured by HPLC.30 C, whereas the value of His-AnCrpB for cAMP was 57.1
lM at 20 C and 57.5 lM at 30 C. These Kd values were al-
most constant in this range of temperature. The predicted
maximum amounts of bound cAMP on His-AnCrpA and His-
AnCrpB were approximately 0.45 and 0.4 molecule on one
molecule, respectively. Therefore, both His-AnCrpA and
AnCrpB might form a dimer and bind one molecule of cAMP.
Indeed, the cross-linking experiment was performed to dem-
onstrate dimer formation (data not shown). That means each
His-AnCrpA and His-AnCrpB form a homodimer binding one
molecule of cAMP. The Kd value of cGMP in His-AnCrpB
was also measured with the same procedures using 50 lMHis-
AnCrpB and 1–500 lM cGMP. The Kd value of His-AnCrpB
for cGMP was estimated to be approximately 150 lM at both
20 and 30 C (data not shown).
Various bacterial CRPs are known to bind with the con-
sensus DNA sequences in the presence of cAMP. To conﬁrm
whether AnCrpA and AnCrpB bind to the consensus DNA
sequences, a gel mobility shift assay was performed. As shown
in Fig. 5A, retarded bands appeared in the presence of cAMP
(lanes 2, 3 and 5), while the band was not detected without
cAMP (Fig. 5A, lanes 6–10) despite the addition of a 30-fold
amount of His-AnCrpA (Fig. 5A, lane 10). The addition of
excess non-labeled DNA probe resulted in the disappearance
of the retarded band (Fig. 5A, lane 4) and the addition of 3-
fold amount of poly(dI–dC) had no eﬀect (Fig. 5A, lane 5).
These results indicate that His-AnCrpA recognizes the CRP
consensus DNA sequence speciﬁcally in the presence of cAMP.
As well as AnCrpA, gel mobility shift assay was also per-
formed using His-AnCrpB and the consensus DNA sequence.
Though AnCrpB lacks ordinary DNA-binding motifs in its
amino-acid sequence and the residue identity of the carboxyl-
terminal region is low in comparison with other CRPs (Fig. 1A
and B), retarded bands were detected at a high concentration
of His-AnCrpB in the presence of 200 lM cAMP (Fig. 5B,
lanes 4–8). These bands were not detected under 100 ng His-
AnCrpB concentration (Fig. 5B, lanes 1–3) or in the absence of
cAMP (Fig. 5B, lanes 10–14). Similar to His-AnCrpA, an in-
crease of poly(dI–dC) did not aﬀect the retarded bands
(Fig. 5B, lanes 4–8), while the excessive non-labeled DNA
probe addition had an eﬀect (Fig. 5B, lane 9). These results
indicate that His-AnCrpB, with its protein structure very dif-
ferent from that of common CRP, was able to recognize the
consensus DNA sequence.4. Discussion
We have identiﬁed two cAMP receptor proteins, AnCrpA
and AnCrpB, in Anabaena sp. PCC 7120. The equilibrium
dialysis measurements demonstrated that His-AnCrpA bound
with cAMP speciﬁcally, while His-AnCrpB shows aﬃnity to
both cAMP and cGMP (Fig. 3). It is generally known that
bacterial CRPs bind with both cAMP and cGMP [37,38], while
AnCrpA and SYCRP1 bind speciﬁcally with cAMP (Fig. 3A,
[14]). Moreover, the Kd value of His-AnCrpA for cAMP was
lower than 1 lM at 20 and 30 C (Fig. 4A). This value is quite
low as compared to the Kd values for other bacterial CRPs, in
the order of 105 M [37,38]. The Kd value of His-AnCrpB for
cAMP was approximately 60 lM at 20 and 30 C (Fig. 4B),
which is almost the same as for Vivrio harveyi CRP [39]. The
distinctions of speciﬁcity and aﬃnity for these CRPs are
Fig. 5. DNA-binding of AnCrpA and AnCrpB. The binding of His-AnCrpA to the bacterial consensus sequence for CRP in the presence (A, lanes 1–
5) or absence (A, lanes 6–10) of cAMP and the binding of His-AnCrpB to the consensus sequence in the presence (B, lanes 1–9) or absence (B, lanes
10–14) of cAMP were examined. 32P-labeled probe DNA (approximately 1 ng) was incubated with the His-AnCrpA or His-AnCrpB, poly(dI–dC)
and with or without non-labeled DNA, which was added in the amounts indicated above each lane in the presence or absence of cAMP. The
positions of the protein–DNA complex and free DNA are indicated by arrows.
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suggested that Asn-80 and Asn-145 of CRP-Syn (synonymous
with SYCRP1) could create a new hydrogen bond with cAMP.
The AnCrpA conserves both amino acid residues, but AnCrpB
does not conserve the residue equivalent to Asn-80 of SYCRP1
or AnCrpA (Fig. 1B), which supports the model.
A consensus DNA sequence for an E. coli CRP-speciﬁc
binding site has been established [41–46]. This sequence is pal-
indromic: a six-base-pair spacer separates two core motifs that
consist of the ﬁve-base-pair sequence 50-TGTGA-30. This se-
quence is also recognized in other bacterial CRPs. Crystallo-
graphic and genetic arguments for the involvement of constants
between this core sequence and functional amino acids, espe-
cially Arg-180, Glu-181 and Arg-185, that participate in DNA-
binding have been reviewed [4,5,47,48]. The carboxyl-terminal
region of AnCrpA shows a high homology to the latter part of
the helix–turn–helix motif of E. coli CRP and includes the three
main functional amino acids that participate in DNA-binding
(Fig. 1B). As a result of the gel mobility shift assay using His-
AnCrpA and the bacterial CRP consensus DNA sequence, it
was concluded that His-AnCrpA bound to the consensus DNA
sequence in a cAMP-dependent manner (Fig. 5A).The AnCrpB lacks an ordinary DNA-binding motif, and
shows a less homologous sequence to the carboxyl-terminal
region of E. coli CRP, SYCRP1, and AnCrpA. Moreover, it
does not have three direct DNA-binding amino acids with the
exception of 181-Glu of E. coli CRP (Fig. 1B), though, sur-
prisingly, His-AnCrpB formed a complex with the consensus
DNA sequence in the presence of 200 lM cAMP (Fig. 5B). It
is suggested that AnCrpB functions as the transcriptional
regulator. Therefore, a prediction of the binding manner of
AnCrpB for the consensus DNA sequence was performed
(Fig. 6B). The corresponding residues of AnCrpB for Arg-180,
Glu-181, and Arg-185 in E. coli CRP are 187-Val, 188-Glu and
192-Lys, respectively (Fig. 1B). The 187-Val of AnCrpB could
not form a hydrogen bond with the DNA because the prop-
erties between Arg and Val are extremely diﬀerent. However,
Glu-188 in AnCrpB is considered to bind with the C4 nucle-
otide in the consensus DNA sequence similar to E. coli CRP as
illustrated in Fig. 6B. Furthermore, 192-Lys in AnCrpB pos-
sibly forms a hydrogen bond with the G4 or T5 nucleotide in
the consensus DNA sequence because both Arg and Lys are
basic amino acid residues, although Arg belongs to a branched
amino group. Hence, 192-Lys in AnCrpB could interact with
Fig. 6. Prediction of hydrogen bonds of AnCrpB for consensus DNA sequence. The schematic drawing was made by FAMS software [53] based on
the crystal structure analysis of the E. coli CRP–cAMP–DNA complex [4]. The plain scheme is indicated at the upper left position of respective
panels. Only nucleotides that interact with functional amino acid residues directly in E. coli CRP (G2, G4, C4 and T5 in the consensus sequence, 5
0-
T1G2T3G4A5-3
0 and 50-T5C4A3C2A1-30) are illustrated on each stereo scheme. Ribbon-shaped helixes indicate recognition helix of E. coli CRP (A),
or putative recognition helix of AnCrpB (B). The amino acid residues are colored according to type: basic, blue; polar, red; and non-polar, yellow.
(A) Mode of binding between the recognition helix of E. coli CRP and the half-side consensus DNA sequence. Hydrogen bonds between the protein
side chains and the consensus DNA sequence (dotted green lines) were quoted from Schultz et al. [4]. (B) Putative schematic drawing between the
predicted recognition helix of AnCrpB and the half-side consensus DNA sequence. Putative hydrogen bonds were denoted by dotted green lines as in
(A). Lys-192 in AnCrpB is considered to interact with either the G4 nucleotide (represented by I) or the T5 nucleotide (represented by II).
T. Suzuki et al. / FEBS Letters 571 (2004) 154–160 159either the G4 nucleotide or T5 nucleotide as described in
Fig. 6B.
The second structural prediction of AnCrpB from 3D-PSSM
ver. 2.6.0 [49] suggested that the corresponding region for theE. coli CRP helix–turn–helix region of AnCrpB possibly forms
two helices that straddle the residues of 184-Glu, 185-Ile and
186-Gly of AnCrpB (data not shown). It is unclear whether the
residues of 184-Glu, 185-Ile and 186-Gly of AnCrpB form a
160 T. Suzuki et al. / FEBS Letters 571 (2004) 154–160turn structure, although most of the a-helical DNA-binding
proteins in bacteria have a helix–turn–helix motif [50]. The
OmpR is an extreme case of the helix–turn–helix variant that is
deﬁned as a ‘‘winged-helix–turn–helix’’ DNA-binding protein
[51,52]. Based on these predictions, it is anticipated that
AnCrpB perhaps belongs to a new subfamily of ‘‘helix–turn–
helix’’ DNA-binding protein.
A speciﬁc sequence interaction in the presence of cAMP
between His-AnCrpA or His-AnCrpB and the consensus DNA
sequence was observed by competition experiments (Fig. 5A
and B), although the respective optimal sequences and the
roles in vivo remain to be identiﬁed. In Synechocystis sp. PCC
6803, SYCRP1 regulated expression of the genes of slr1667
and slr1668 that could be involved in cell motility [15,16].
However, Anabaena sp. PCC 7120 shows no cell motility,
suggesting that AnCrpA and AnCrpB regulate genes for not
cell motility but other signal transduction pathways. Particu-
larly, AnCrpB may function in an extreme cellular condition
where the cAMP level becomes very high. It is very interesting
that Anabaena sp. PCC 7120 possesses two cAMP receptor
proteins that show diﬀerent biochemical properties, and their
physiological roles should be elucidated.
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